[HTML][HTML] Efficacy and safety of neoadjuvant immunotherapy protocols and cycles for non-small cell lung cancer: a systematic review and meta-analysis
H Wang, S Liang, Y Yu, Y Han - Frontiers in Oncology, 2024 - frontiersin.org
Objectives This study evaluated the use of different neoadjuvant immunotherapy cycles and
regimens for non-small cell lung cancer. Materials and methods Databases were searched …
regimens for non-small cell lung cancer. Materials and methods Databases were searched …
Predictors, surrogate, and patient-reported outcomes in immunotherapy and salvage surgery for unresectable lung cancer: a single-center retrospective study
S Mohamed, L Bertolaccini, M Casiraghi, F Petrella… - Updates in Surgery, 2023 - Springer
Medical treatment has changed drastically in recent years, especially for advanced stages of
non-small-cell lung cancer (NSCLC), for which the development of immunotherapy and …
non-small-cell lung cancer (NSCLC), for which the development of immunotherapy and …
Is response evaluation criteria in solid tumors (RECIST) effective in patient selection for radical resection after neoadjuvant immunotherapy with advanced NSCLC?
Y Xu, D Ma, Y Qin, S Li, J Li, Y Jiang, M Wang… - Thoracic …, 2023 - Wiley Online Library
Background Neoadjuvant immunotherapy combined with chemotherapy has been used to
treat locally advanced non–small cell lung cancer (NSCLC). Several systems have been …
treat locally advanced non–small cell lung cancer (NSCLC). Several systems have been …